Whilst Mounjaro has demonstrated significant efficacy in glycaemic control and weight reduction in clinical trials, gastrointestinal side effects are amongst the most commonly reported adverse reactions
The role of neural plasticity in depression: from hippocampus to prefrontal cortex
However, this slower movement can occasionally lead to a backup sensation
"LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept." Cell Metabolism , 2022
These are cases where both primary and side effects can clash with individual disorders and either become much worse than usual, or act against the way the medicines are supposed to
This regulatory distinction creates substantial patient safety concerns